1-248295007-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004692.2(OR2T12):c.572C>T(p.Ser191Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000348 in 1,610,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T12 | NM_001004692.2 | c.572C>T | p.Ser191Leu | missense_variant | 3/3 | ENST00000641276.1 | NP_001004692.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T12 | ENST00000641276.1 | c.572C>T | p.Ser191Leu | missense_variant | 3/3 | NM_001004692.2 | ENSP00000493000.1 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151142Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251114Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135716
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1459716Hom.: 0 Cov.: 103 AF XY: 0.0000289 AC XY: 21AN XY: 726164
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151142Hom.: 0 Cov.: 28 AF XY: 0.0000136 AC XY: 1AN XY: 73754
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.572C>T (p.S191L) alteration is located in exon 1 (coding exon 1) of the OR2T12 gene. This alteration results from a C to T substitution at nucleotide position 572, causing the serine (S) at amino acid position 191 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at